Skandinaviska Enskilda Banken (SEB)’s Arcturus Therapeutics ARCT Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-27,539	Closed	-$292K	–	847
2025 Q1	$292K	Hold	27,539	–	–	﹤0.01%	726
2024 Q4	$457K	Hold	27,539	–	–	﹤0.01%	721
2024 Q3	$639K	Hold	27,539	–	–	﹤0.01%	704
2024 Q2	$671K	Hold	27,539	–	–	﹤0.01%	670
2024 Q1	$930K	Buy	+27,539	New	+$976K	﹤0.01%	664
2022 Q3	–	Sell	-6,603	Closed	-$104K	–	898
2022 Q2	$104K	Hold	6,603	–	–	﹤0.01%	927
2022 Q1	$178K	Hold	6,603	–	–	﹤0.01%	893
2021 Q4	$257K	Hold	6,603	–	–	﹤0.01%	889
2021 Q3	$315K	Sell	6,603 -18,614	-74%	-$834K	﹤0.01%	899
2021 Q2	$853K	Buy	+25,217	New	+$854K	0.01%	831

Other funds holding ARCT

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s ARCT Position: Q2 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Arcturus Therapeutics (ARCT) in Q2 2025, closing a stake of 27,539 shares — an estimated $292K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in ARCT in Q2 2021 and held it in 10 quarters. The position peaked at $930K in Q1 2024. 143 funds tracked by Wall St. Rank hold ARCT as of Q2 2025.

Skandinaviska Enskilda Banken (SEB) reported no remaining Arcturus Therapeutics position as of Q2 2025 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 27,539 Arcturus Therapeutics shares in Q2 2025, an estimated $292K.
Skandinaviska Enskilda Banken (SEB) first reported a position in Arcturus Therapeutics in Q2 2021 and held it in 10 quarters.
Skandinaviska Enskilda Banken (SEB)'s Arcturus Therapeutics position peaked at $930K in Q1 2024.
143 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2025, filed 13 Aug 2025.